secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001213900-26-003166
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies raises $7.53M via warrant exercise inducement from all 9 existing holders
--------------------------------------------------------------------------------

- Gross proceeds of $7.53M from exercise or pre-funding of 5,382,148 Existing Warrants at $1.40/share.
- New Warrants issued for up to 5,382,148 shares at $1.40, exercisable immediately for 5 years.
- Net proceeds to fund OST-HER2 BLA/MMA filings, commercial prep, and OS Animal Health spinoff.
- BLA for OST-HER2 in metastatic osteosarcoma expected by end of January 2026 under Accelerated Approval.
- Company expects cash runway into 2027; all 9 accredited investors offered agreed to participate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026003166/0001213900-26-003166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026003166/ea0272516-8k_ostherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-003166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer